Protocol Ledger

NCT05608044 · Phase II · ACTIVE NOT RECRUITING

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

Interventional Phase II clinical trial protocol NCT05608044 sponsored by Agenus in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-11-30 Enrollment: 234 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05608044
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)234 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05608044
Protocol FieldVerified Registry Value
NCT IdentifierNCT05608044
Consolidated Lead SponsorAgenus
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment234 participants (ACTUAL)
Registered Start Date2022-11-30
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI